FormWeb • insulin glargine

Approved Hospital Formulary

Formulary Addition Requisition (Position 1)

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Approved Hospital Formulary

Formulary Addition Requisition (Position 1)

insulin glargine

Drug Name	Form	Strength	Non-Formulary	Restricted	Renal Dosing	REMS	Therapeutic Interchange	Notes
Lantus	SOLUTION, SUBCUTANEOUS	100 units/mL
Lantus Solostar Pen	SOLUTION, SUBCUTANEOUS	100 units/mL

VIEW MORE Long-Acting Insulins
CLASS

Additional Information:

Drug Name	Common Side Effects
insulin glargine	low blood sugar: confusion, dizzy, hunger, shaky weight gain scarring of fat tissue (lipodystrophy)

Last updated: Aug. 22, 2022

For further information regarding Formweb
please call 800.467.1907.